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Collections of leukocytes in the meningeal space have been documented in Multiple 
Sclerosis (MS). These meningeal aggregates, which in the context of other autoimmune 
diseases have often been termed tertiary lymphoid tissues (TLT), have been associated 
with sub-pial cortical damage and disease progression. However, the key molecular 
and cellular signals required for their formation and maintenance remain unclear. Herein, 
we review TLT structures in other disease states in order to provide a framework for 
understanding these structures in the MS meninges. We then assess the evidence 
that the meningeal compartment serves as an important nexus for immune cells as 
well as a location for drainage of antigen into cervical lymph nodes. Extrapolating what 
is known about the molecular and cellular cues that initiate the formation of leukocyte 
aggregates in non-lymphoid tissues, we speculate on what signals lead to the formation 
and maintenance of meningeal TLT structures. Referring to the animal model of MS 
[experimental autoimmune encephalomyelitis (EAE)], we also explore what is known 
about these structures in supporting B cell and T cell responses during neuroinflam-
mation. Last, we examine the evidence that connects these structures to ongoing 
neuropathology. Collectively, our review points to the meningeal compartment as an 
important player in neuroinflammatory processes. Moreover, we hypothesize that in 
order to gain insights into pro- and anti-inflammatory properties of lymphocytes in MS, 
one must understand the cellular scaffolds that support lymphocyte retention within the 
meninges, thus highlighting the importance of non-immune cells (stromal cells) in the 
neuroinflammatory process.
Keywords: meninges, multiple sclerosis, experimental autoimmune encephalomyelitis, tertiary lymphoid tissues, 
stromal cells
OveRview
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) resulting 
in demyelination and axonal loss with consequential clinical impairment. MS is most commonly 
diagnosed as relapsing-remitting MS (RRMS), which is thought to reflect the waxing and waning 
of underlying CNS-targeted immune responses. Most individuals with RRMS go on to develop a 
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progressive form of MS, termed secondary progressive MS. The 
relative absence of new gadolinium-enhancing lesions in the CNS 
of individuals with progressive MS has for a long-time supported 
the hypothesis that there is limited infiltration of peripheral 
immune cells into the CNS at this stage of disease (1). This concept 
has been recently challenged following the observation of menin-
geal leukocytic infiltrates (consisting of T cells, B cells, plasma 
cells, monocytes and macrophages) in both SPMS [in as many as 
40% of cases; (2–4)] and Primary Progressive MS (5), correlating 
with proximal neuropathology (6). However, meningeal inflam-
mation may also contribute to neuroinflammatory processes early 
on in MS, and recent MRI studies demonstrate leptomeningeal 
contrast enhancement in RRMS [~19% of cases; (7)].
Meningeal leukocytic aggregates have been referred to as 
tertiary lymphoid tissues (TLT), provoking the hypothesis that 
such aggregates support disease-relevant immune responses 
locally within the CNS. Although there is some discrepancy as to 
whether meningeal follicle-like structures recapitulate all of the 
features of TLT, for the purposes of this review, we will refer to 
them as TLT (8–10).
TeRTiARY LYMPHOiD TiSSUeS
Tertiary lymphoid tissues (TLT) are locally inducible leukocyte 
aggregates that form in chronically inflamed non-lymphoid 
tissues and share cellular and organizational similarities with 
secondary lymphoid organs (SLO). TLT arise within the target 
tissues of many autoimmune diseases and certain sites of chronic 
infection, including in the synovial membrane of the joints (rheu-
matoid arthritis), salivary glands (Sjögren’s syndrome), thymus 
(Mysasthenia gravis and Grave disease), meninges (MS), the liver 
(hepatitis C viral infection), the lung (Influenza A viral infection), 
as well as at sites of chronic graft rejection, atherosclerosis, and 
cancer (8, 10). The majority of information we have on TLT struc-
ture and formation is from disease settings that do not involve 
the CNS. This may be due to the limitations in studying TLT 
in post-mortem tissue (brain tissue from autopsies tends to be 
obtained very late in the disease process when inflammation may 
be less pronounced), the relatively smaller size of meningeal TLT, 
and variability in histology and dissection protocols for assessing 
meningeal TLT. As such, this section will focus on what we have 
learned about TLT in other disease settings that may be more 
amenable to study, and we will then apply these findings to CNS 
autoimmunity in a subsequent section.
TLT Structure
Lymphoid architecture is orchestrated by specialized stromal cell 
subsets. Follicular dendritic cells (FDC; CD45−CD31−Pdpn±) 
and recently defined Cxcl12-expressing reticular cells (CRC; 
CD45−CD31−Pdpn±) (11) secrete B cell chemoattractants 
CXCL13 and CXCL12, respectively. FDC further upregulate 
molecules involved in trapping and presenting antigen (CD35, 
FDC-M1, and FDC-M2) to support germinal center responses. 
The T cell zone is supported by fibroblastic reticular cells (FRC; 
CD45−Pdpn+CD31−) that secrete T cell chemoattractants (CCL19, 
CCL21) as well as T and B cell survival factors (IL-7, BAFF) and 
form long reticular channels supporting the passage of antigen 
through the lymphoid organ (12). TLT encompass a spectrum of 
lymphoid tissue-like organization depending on the target tissue. 
TLT are primarily described as B cell-rich infiltrates, with a vary-
ing degree of T cell infiltration and sometimes segregation into 
distinct B and T cell compartments resembling SLO architecture. 
Although FDC markers have been detected within TLT in vari-
ous chronic inflammatory conditions, not all TLT demonstrate 
germinal centers or reticular conduits reminiscent of FRC (10, 13, 
14). Mature TLT can also contain high endothelial venules (HEV) 
and lymphatic vessels, suggesting an avenue for entry of naive 
lymphocytes (via the HEV) and egress of antigen and activated 
or memory lymphocytes via lymphatic vessels (15).
TLT Formation
Lymphorganogenesis requires the well-defined interaction 
of embryonic/neonatal lymphoid tissue inducer cells (LTi; 
CD45+CD4+CD3−) with stromal lymphoid tissue organizer cells 
(LTo) to promote LTo maturation into specialized lymphoid stro-
mal cells that in turn form an immune-competent niche [reviewed 
by Ref. (12, 16–20)]. In the context of lymphoneogenesis in the 
adult host, distinct cell types may substitute as TLT inducer 
and organizer cells. LTi equivalent cell types implicated in TLT 
formation include: innate lymphoid cells (21–23), T cells (24–27), 
NKT cells (28), as well a myeloid cells (28, 29). Although the exact 
combination of molecular cues may differ, a unifying feature of 
TLT-inducing leukocytes is their production of cytokines, espe-
cially IL-17 [reviewed by Ref. (30)] and/or IL-22 (21, 22, 27), and 
their ability to engage receptors of the Tumor Necrosis Factor 
(TNF) superfamily (LTβR, TNFR) by virtue of their expression 
of cognate ligands LTαβ and TNFα.
The origin and phenotype of TLT organizer cells remains 
more elusive. Seminal studies have demonstrated that stromal 
precursor cells reside quiescently throughout the periphery, 
and mature to acquire phenotypic and functional capacities 
consistent with lymphoid tissue stromal cells in response to 
inflammation (29, 31). A population of CD45−CD31−Pdpn− cells, 
which transcriptionally most closely resemble FRCs (32), has 
also been demonstrated to differentiate into de novo FRCs in the 
inflamed LN (33, 34), illustrating that even within adult SLOs, 
mesenchymal precursors can recapitulate an LTo-like function. 
Nevertheless, further studies are needed in order to elucidate to 
what extent mesenchymal precursor cells in the adult host resem-
ble embryonic LTos and how such LTo-like cells differentiate in 
order to support emerging TLT.
Several markers have been useful for assessing the phenotype 
of tissue-resident stromal cells, including: podoplanin (Pdpn or 
gp38); the endothelial cell marker, CD31; EPCAM, a marker 
of epithelial cells; as well as the expression of homeostatic 
chemokines. For example, in several models of TLT formation, 
peripheral Pdpn+ stromal cells express CXCL13 (26, 27, 29, 31), 
while in a model of atherosclerosis, vascular smooth muscle 
cells were found to express both CXCL13 and CCL21 within 
aortic TLT (35). Both Pdpn+CD31− stromal cells and EPCAM+ 
epithelial cells express CXCL12 within TLT in the lungs (26) 
and salivary glands (27), respectively. Nevertheless, without a 
consistent panel of mesenchymal/lymphoid stromal cell markers 
applied to different models of TLT formation, it is difficult to 
TABLe 1 | Association of immune cell phenotypes and pathology with TLT.
Feature evidence Reference
B cell 
responses – EAE
B cell-rich meningeal aggregates during 
EAE
(36)
(40)
(24)
FDC-M1- and CD35-immunoreactive cells 
(FDC-like cells) and CXCL13 transcripts 
within meningeal TLT
(36)
B cell responses – MS B cell- and plasma cell-rich meningeal TLT (2)
(41)
CD35- and CXCL13-immunoreactive cells 
(FDC-like cells) within meningeal TLT
(2)
Activated B cells (clonal expansion, 
somatic hypermutation, Ig class switching) 
within meningeal aggregates
(42)
(43)
(44)
(45)
T cell 
responses – EAE
T cells infiltrate the meninges and 
are reactivated in the subarachnoid 
compartment
(46)
(47)
(48)
(49)
(50)
T cell epitope spreading concurrent with 
presence of meningeal TLT
(37)
Th17 cells contribute to meningeal TLT 
formation
(51)
(24)
(52)
T cell responses – MS T cell accumulation within meningeal TLT (4)
(53)
(5)
Neuropathology – MS Cortical demyelination (54)
(3)
(6)
(53)
(4)
(5)
Glial limitans damage, increased microglial 
activation
(3)
(6)
(4)
(41)
Cortical astrocyte and oligodendrocyte loss (6)
Neuronal loss (6)
(5)
Clinical correlates Earlier age of clinical onset, faster time of 
disease progression, earlier age at death
(3)
(4)
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interpret whether different inflammatory insults instigate distinct 
maturation protocols from ubiquitous precursor cells, or whether 
tissue-specific differences exist.
In summary, our current understanding is that precursors 
of lymphoid-like stromal cells reside quiescently throughout 
peripheral non-lymphoid tissues and are poised to mature into 
lymphoid stromal cells at sites of persistent inflammation. In 
response to local inflammatory cues, tissue-resident stromal cells 
acquire phenotypic and functional capacities consistent with 
lymphoid tissue stromal cells.
STRUCTURe AnD FUnCTiOn OF 
MeninGeAL TLT DURinG CnS 
AUTOiMMUniTY
Meningeal aggregates in the MS CNS are often referred to as TLT; 
however, as is true for ectopic lymphoid tissues in general, this 
term captures a range of lymphoid tissue-like organization. Animal 
studies characterizing meningeal inflammation in EAE demon-
strate TLT formation in mice with different genetic backgrounds 
and disease-induction protocols (24, 36–39). These meningeal 
infiltrates often resemble mature TLT, with the presence of lym-
phoid-like stromal cells, elaboration of an extra-cellular matrix 
(ECM) network, and expression of cytokines and homeostatic 
chemokines. Below, we will review our current understanding 
about the structure and capacity for the meninges to support TLT 
formation, as well as the clinical and neuropathological correlates 
of meningeal TLT in both MS and EAE (see also Table 1).
Anatomical Structure of the Meninges
The meninges are a series of membranes that envelope the brain 
and spinal cord, serving as a canal for circulating cerebrospinal 
fluid (CSF). The outermost membrane is the dura, which 
cocoons the CNS and is attached to the skull and spinal column. 
The leptomeninges that envelope the entire CNS consist of the 
arachnoid and pia mater and are separated by the subarachnoid 
space. Large conducting blood vessels transecting the leptome-
ninges are embedded within the pia mater, which is lined by the 
glial limitans, a barrier comprising astrocytic end-foot processes 
(55). Cells of the pia mater continue to line intracerebral arter-
ies but gradually become less dense as the arteries penetrate the 
CNS parenchyma (56–58). The meningeal space is depicted in 
Figure 1. Cells that reside in the meningeal compartment include 
fibroblasts and peri-endothelial cells (myofibroblasts, pericytes, 
and vascular smooth muscle cells), as well as CNS-resident 
macrophages and dendritic cells. A recent study by Louveau 
and colleagues has revealed the presence of lymphatic vessels 
within the dural sinuses, implying there is direct communication 
between the meningeal environment and the draining cervical 
LNs (cLN) (59).
The Meninges – A Portal of Leukocyte 
entry and Accumulation in the 
inflamed CnS
The blood endothelium transecting the subarachnoid space (the 
blood–CSF barrier) represents an important route of leukocyte 
entry into the meninges. In the steady state, the subarachnoid 
space represents an avenue for immune-surveying lymphocytes 
to scan the CNS (60). Studies examining the kinetics of meningeal 
infiltration in EAE report an influx of immune cells prior to clini-
cal onset (39). In addition, using specialized fluorescent reporter 
mice and two-photon live imaging, myelin-specific T cells have 
been shown to first cross the blood–CSF barrier in the suba-
rachnoid space, where antigen-specific re-priming must occur 
in order to gain access to the parenchyma and instigate clinical 
symptoms of EAE (47). With respect to MS, biopsies from early 
stage MS patients identified a subset of patients with evidence of 
cortical demyelinating lesions associated with meningeal inflam-
mation (53). Moreover, a recent study has estimated that almost 
20% of individuals with RRMS demonstrate meningeal contrast 
enhancement (7).
EAE studies, post-mortem histological analyses, and CSF 
samplings all demonstrate that accumulation of proliferating, 
FiGURe 1 | Depiction of the meninges in the healthy brain. The meninges consist of three layers: the dura is the outermost layer, followed by the arachnoid 
and pia, which form the leptomeninges. Lymphatic vessels embedded within the dura drain the sagittal sinus (not depicted). The vasculature transecting the 
meninges is embedded within the pial cell layer, and represents a route of leukocyte entry into the CNS.
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antigen-experienced T cells (48, 61, 62), and B cells (3, 4, 42–45) 
can occur within the meningeal compartment itself during CNS 
autoimmunity. In terms of T cell responses, epitope spread-
ing of myelin-reactive T cells is suggested to occur within the 
meninges (37). While antigen-presenting phagocytic cells have 
been shown to productively interact with myelin-specific T 
cells in the subarachnoid space (46, 48–50), recent studies also 
demonstrate that meningeal stromal cells may be important for 
propagating encephalitogenic T cell responses within the CNS 
(52). With respect to meningeal B cell responses, class-switched 
memory B cells and plasmablasts/plasma cells have long been 
detected in the CSF of individuals with MS, and contribute to 
intrathecal production of antibodies, a hallmark of MS (43, 
63). While  antigen-experienced B cells populate the meningeal 
compartment, clonally related B cells are also located in paren-
chymal lesions, the normal-appearing white matter (42), and 
in the periphery (44, 45, 64), making it unclear where B cells 
are first primed. The presence of myelin antigens in the cLN 
of individuals with MS, but not healthy controls (65), and the 
discovery of lymphatics draining from the meningeal space to 
cLN (59) suggest that antigen-dependent B cell responses can be 
initiated in the cLN. Recently, deep sequencing analyses of the B 
cell receptor variable heavy chain (VH) between matched CNS 
and peripheral samples demonstrated that upwards of 90% of 
founder B cell clones were localized within cervical lymph node 
tissues (44). However, it remains possible that the spatial–tem-
poral distribution of founder clones differs at disease onset. In 
summary, the blood–CSF barrier is an important portal of entry 
for leukocytes into the CNS. The subarachnoid space represents 
an important site of accumulation for activated lymphocytes, as 
well as dendritic cells (46), neutrophils, and mast cells (39, 66) 
within the inflamed CNS.
How Do TLT Form within the Meninges?
The presence of immune cells in the meninges and CSF of 
individuals with MS does not in and of itself confirm that the 
meninges constitute an immune-competent niche. To endow 
“immune competence,” such an environment would need to be 
populated by stromal support cells that secrete lymphocyte chem-
oattractants (such as CXCL13, CCL19, CCL21) and possibly also 
survival/differentiation factors (cytokines). Indeed, meningeal 
stromal cells have the capacity to secrete mediators such as TNFα, 
iNOS, IL-6, TGF-β, and IL-23 under inflammatory conditions 
(52, 67). Pro-inflammatory cytokines themselves can induce lym-
phocytic accumulation within the meningeal compartment, as 
demonstrated following injection of TNFα and IFNγ directly into 
the subarachnoid space (68) or intra-cortically (69) in rodents 
immunized sub-clinically with MOG. While these studies did 
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not examine whether cytokine-induced TLT-like aggregates are 
supported by an underlying stromal cell and ECM network, TLT 
surrounded by a reticular network have been observed upon 
adoptive transfer of IL-17 producing encephalitogenic T cells in 
mice (24).
Expression of both T cell and B cell chemoattractants and 
lymphoid-like FRCs and FDCs has been demonstrated in the 
inflamed CNS. In both EAE and MS, CXCL13 expression and 
FDC-like cells (CD35+ and FDC-M1+) are reported within B 
cell-rich meningeal aggregates (2, 36, 40), while CCL19 and 
CCL21 transcripts have been detected within parenchymal and 
sub-meningeal lesions in the brains of SWR/J ×  SJL/J F1 mice 
with EAE (38). In the context of MS, over three decades ago, 
Prineas and colleagues described the presence of reticular-like 
cells embedded within lymphoid-like structures and lymphatic 
capillaries within old plaques in the MS CNS (70). While the 
phenotype of these reticular cells has not since been explored 
in the MS CNS, the elaboration and maturation of a reticular 
lymphoid-like stromal cell network were recently described in the 
brain meninges of mice with Th17 adoptive transfer EAE (52). 
FRC-like stromal cells were found to secrete pro-inflammatory 
cytokines, homeostatic chemokines (CXCL13, CCL21), as well 
as CXCL1 and BAFF, forming an immune-competent micro-
environment. IL-17- and IL-22-derived signals were shown to 
promote the physical elaboration of the reticular network while 
acquisition of lymphoid-like stromal cell properties was in part 
lymphotoxin dependent, suggesting that multiple pathways 
culminate in the elaboration of an immune-regulatory stromal 
cell scaffold in the inflamed CNS. In summary, the meninges are 
a CNS environment poised to establish an inflammatory niche 
that is capable of supporting immune-responses within the CNS.
Meningeal inflammation and Cortical 
Pathology in MS
Cortical lesions characterized by demyelination, axonal atro-
phy, and microglial activation in the sub-pial mater have been 
shown to underly meningeal lymphocytic infiltrates in the 
progressive MS CNS (3, 5, 54), although another study failed 
to see a correlation between meningeal inflammation and 
sub-pial demyelination (71). The presence of meningeal TLT in 
SPMS correlates with accelerated clinical disease (earlier age of 
clinical onset, faster time of disease progression and earlier age 
of death) compared to SPMS cases without meningeal TLT (4). 
It is postulated that soluble factors emanating from meningeal 
lymphocytic aggregates degrade the glial limitans, promoting a 
gradient of demyelination and neuronal injury (3, 6). While B 
cells, plasma cells (IgA+, IgG+, IgM+), CD4+ and CD8+ T cells, 
monocytes/macrophages infiltrate the subarachnoid space, a 
recent study revealed that only the accumulation of plasma cells 
and macrophages was significantly elevated in meningeal TLT 
compared to region-matched controls, and the accumulation of 
these particular cell types was associated with underlying cerebel-
lar gray matter demyelination (41). In addition, the accumula-
tion of meningeal CD3+ T cells correlates with axonal loss and 
microglial activation in the underlying normal-appearing white 
matter in the spinal cord in progressive MS (72). Taken together, 
these observations may reflect distinct susceptibility of different 
regions of the CNS to immune cell-mediated injury.
COnCLUSiOnS
The presence and inducible formation of an immune-competent 
niche in the meninges suggests that these structures may sup-
port disease-relevant immune responses in the CNS. While 
TLT-associated immune responses are proposed to contribute to 
ongoing neuropathology and disease exacerbation, these struc-
tures likely evolve to support cell types regulating the balance 
of pro-inflammatory and anti-inflammatory responses in the 
meninges. Indeed, the accumulation of regulatory T cells within 
chronic aortic TLT is associated with clinical benefit in a rodent 
model of atherosclerosis (35). On the other hand, the presence of 
TLT in cases of enteropathic infection or cancer is associated with 
clinical benefit (21, 22, 73, 74). Therefore, one must consider that 
the cellular constituents of meningeal TLT may change over time, 
implicating altered neuropathological and clinical consequences 
within the inflamed CNS. We propose that an understanding of 
the cellular scaffolds that support lymphocyte retention within 
the meninges (i.e., specialized non-immune stromal cells) will 
lead to a better understanding of the meningeal compartment in 
the context of MS/EAE.
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